NASDAQ:SILK Silk Road Medical (SILK) Stock Forecast, Price & News $15.81 +0.13 (+0.83%) (As of 02:21 PM ET) Add Compare Share Share Today's Range$15.30▼$16.1450-Day Range$15.68▼$23.1552-Week Range$15.03▼$58.04Volume230,065 shsAverage Volume663,731 shsMarket Capitalization$613.90 millionP/E RatioN/ADividend YieldN/APrice Target$37.60 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability Silk Road Medical MarketRank™ ForecastAnalyst RatingHold2.33 Rating ScoreUpside/Downside137.7% Upside$37.60 Price TargetShort InterestHealthy3.94% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews Sentiment0.56Based on 7 Articles This WeekInsider TradingSelling Shares$210,404 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.46) to ($1.36) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.49 out of 5 starsMedical Sector129th out of 968 stocksSurgical & Medical Instruments Industry19th out of 90 stocks 4.2 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 5 buy ratings, 2 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $37.60, Silk Road Medical has a forecasted upside of 137.7% from its current price of $15.82.Amount of Analyst CoverageSilk Road Medical has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.94% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Silk Road Medical has recently increased by 3.38%, indicating that investor sentiment is decreasing. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 3.1 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 0.56. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Silk Road Medical this week, compared to 3 articles on an average week.Search Interest5 people have searched for SILK on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.MarketBeat Follows2 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $210,404.00 in company stock.Percentage Held by InsidersOnly 6.70% of the stock of Silk Road Medical is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.46) to ($1.36) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -11.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -11.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 3.68. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Silk Road Medical (NASDAQ:SILK) StockSilk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.Read More SILK Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SILK Stock News HeadlinesSeptember 22, 2023 | msn.comArgus Research Downgrades Silk Road Medical (SILK)September 21, 2023 | finance.yahoo.comSilk Road Medical, Inc: Downgrading to HOLD from BUYSeptember 22, 2023 | UNKNOWN (Ad)Space CEO Featured on Good Morning AmericaA $25 Billion Earth Observation Market by 2040. Learn moreSeptember 21, 2023 | finance.yahoo.comEnphase Energy upgraded, Brighthouse downgraded: Wall Street's top analyst callsSeptember 7, 2023 | msn.comOppenheimer Initiates Coverage of Silk Road Medical (SILK) with Outperform RecommendationSeptember 6, 2023 | markets.businessinsider.comAnalyst Expectations for Silk Road Medical's FutureSeptember 6, 2023 | markets.businessinsider.comMedical Device Provider Silk Road Pioneers Innovative Stroke Prevention Method: AnalystSeptember 4, 2023 | finance.yahoo.comSilk Road Medical to Present at the CL King 21st Annual Best Ideas ConferenceSeptember 22, 2023 | UNKNOWN (Ad)Space CEO Featured on Good Morning AmericaA $25 Billion Earth Observation Market by 2040. Learn moreAugust 10, 2023 | msn.comSilk Road Medical: Unsure On Economics Given List Of Probabilities (Rating Downgrade)August 3, 2023 | msn.comSilk Road Medical (SILK) Price Target Decreased by 15.22% to 39.78August 2, 2023 | finance.yahoo.comQ2 2023 Silk Road Medical Inc Earnings CallAugust 2, 2023 | finance.yahoo.comSilk Road Medical, Inc (NASDAQ:SILK) Q2 2023 Earnings Call TranscriptAugust 2, 2023 | markets.businessinsider.comBank of America Securities Sticks to Its Sell Rating for Silk Road Medical (SILK)August 2, 2023 | msn.comSilk Road Medical GAAP EPS of -$0.35 beats by $0.03, revenue of $45.3M beats by $2.13MAugust 1, 2023 | finance.yahoo.comSilk Road Medical Reports Second Quarter 2023 Financial ResultsJuly 31, 2023 | markets.businessinsider.comB.Riley Financial Reaffirms Their Buy Rating on CareCloud (CCLD)July 25, 2023 | fool.comSilk Road Medical (NASDAQ: SILK)July 18, 2023 | markets.businessinsider.comWolfe Research Reaffirms Their Sell Rating on Silk Road Medical (SILK)July 14, 2023 | sg.finance.yahoo.comSILK - Silk Road Medical, IncJuly 13, 2023 | msn.comB of A Securities Downgrades Silk Road Medical (SILK)July 12, 2023 | msn.comSilk Road Medical falls after Medicare decision on stroke treatmentJuly 12, 2023 | markets.businessinsider.comWhy Silk Road Medical Stock Is Plunging TodayJuly 12, 2023 | markets.businessinsider.comB.Riley Financial Sticks to Their Buy Rating for Silk Road Medical (SILK)July 12, 2023 | msn.comBiggest stock movers today: CBL International and Silk Road MedicalJuly 11, 2023 | msn.comCitigroup Reiterates Silk Road Medical (SILK) Buy RecommendationJuly 11, 2023 | finance.yahoo.comSilk Road Medical to Report Second Quarter 2023 Financial Results on August 1, 2023See More Headlines Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address SILK Company Calendar Last Earnings8/01/2023Today9/22/2023Next Earnings (Estimated)11/14/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees414Year FoundedN/APrice Target and Rating Average Stock Price Forecast$37.60 High Stock Price Forecast$55.00 Low Stock Price Forecast$13.00 Forecasted Upside/Downside+139.8%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,010,000.00 Net Margins-32.83% Pretax Margin-32.47% Return on Equity-40.05% Return on Assets-22.40% Debt Debt-to-Equity Ratio0.48 Current Ratio9.69 Quick Ratio8.90 Sales & Book Value Annual Sales$138.64 million Price / Sales4.39 Cash FlowN/A Price / Cash FlowN/A Book Value$4.30 per share Price / Book3.65Miscellaneous Outstanding Shares38,830,000Free Float36,231,000Market Cap$608.85 million OptionableNot Optionable Beta1.16 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMs. Erica J. Rogers (Age 60)Pres, CEO & Director Comp: $1.17MMr. Lucas W. Buchanan (Age 45)CFO & COO Comp: $870.55kMr. Kevin M. Klemz (Age 62)EVP, Chief Legal Officer & Sec. Comp: $644.12kMr. Andrew S. Davis (Age 54)Chief Commercial Officer Comp: $836.33kMr. Richard M. Ruedy (Age 56)Exec. VP of Clinical, Regulatory Affairs & Quality Assurance Comp: $542.41kMs. Mhairi L. Jones (Age 52)Chief Accounting Officer & VP of Fin. Ms. Tammy LeitsingerCompliance Officer & VP of Medical AffairsMr. Matthew McCarthyVP of MarketingMs. Alison HighlanderVP of HRDr. Sumaira MacDonald M.D.Ph.D., Exec. Medical DirectorMore ExecutivesKey CompetitorsArtivionNYSE:AORTIRadimedNASDAQ:IRMDNevroNYSE:NVROAtrionNASDAQ:ATRIOrthoPediatricsNASDAQ:KIDSView All CompetitorsInsiders & InstitutionsPortside Wealth Group LLCBought 49,176 shares on 9/1/2023Ownership: 0.127%Alberta Investment Management CorpBought 6,832 shares on 8/24/2023Ownership: 0.087%California State Teachers Retirement SystemSold 825 shares on 8/21/2023Ownership: 0.120%Osaic Holdings Inc.Sold 1,935 shares on 8/21/2023Ownership: 0.020%Kevin M KlemzSold 1,539 sharesTotal: $30,949.29 ($20.11/share)View All Insider TransactionsView All Institutional Transactions SILK Stock - Frequently Asked Questions Should I buy or sell Silk Road Medical stock right now? 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares. View SILK analyst ratings or view top-rated stocks. What is Silk Road Medical's stock price forecast for 2023? 9 brokerages have issued 1-year price targets for Silk Road Medical's stock. Their SILK share price forecasts range from $13.00 to $55.00. On average, they expect the company's stock price to reach $37.60 in the next twelve months. This suggests a possible upside of 139.8% from the stock's current price. View analysts price targets for SILK or view top-rated stocks among Wall Street analysts. How have SILK shares performed in 2023? Silk Road Medical's stock was trading at $52.85 on January 1st, 2023. Since then, SILK stock has decreased by 70.3% and is now trading at $15.68. View the best growth stocks for 2023 here. When is Silk Road Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023. View our SILK earnings forecast. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings data on Tuesday, August, 1st. The company reported ($0.35) EPS for the quarter, topping analysts' consensus estimates of ($0.39) by $0.04. The company earned $45.30 million during the quarter, compared to analyst estimates of $43.32 million. Silk Road Medical had a negative net margin of 32.83% and a negative trailing twelve-month return on equity of 40.05%. What ETFs hold Silk Road Medical's stock? ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include American CenturyFocused Dynamic Growth ETF (FDG).iShares U.S. Medical Devices ETF (IHI). What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $180.00 million-$184.00 million, compared to the consensus revenue estimate of $179.54 million. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA). When did Silk Road Medical IPO? (SILK) raised $75 million in an initial public offering on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. What is Silk Road Medical's stock symbol? Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK." Who are Silk Road Medical's major shareholders? Silk Road Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Bank Julius Baer & Co. Ltd Zurich (49.17%), Wasatch Advisors LP (13.55%), BlackRock Inc. (7.64%), Alliancebernstein L.P. (6.42%), Clearbridge Investments LLC (4.47%) and Bellevue Group AG (3.49%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Kevin M Klemz, Lucas W Buchanan, Richard Ruedy and Tony M Chou. View institutional ownership trends. How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Silk Road Medical's stock price today? One share of SILK stock can currently be purchased for approximately $15.68. How much money does Silk Road Medical make? Silk Road Medical (NASDAQ:SILK) has a market capitalization of $608.85 million and generates $138.64 million in revenue each year. The company earns $-55,010,000.00 in net income (profit) each year or ($1.41) on an earnings per share basis. How many employees does Silk Road Medical have? The company employs 414 workers across the globe. How can I contact Silk Road Medical? Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The official website for the company is www.silkroadmed.com. The company can be reached via phone at (408) 720-9002, via email at investors@silkroadmed.com, or via fax at 408-720-9013. This page (NASDAQ:SILK) was last updated on 9/22/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.